J-1149 is a potent ALK5 inhibitor, with an IC 50 value of 0.017 μM. J-1149 also shows weak p38α MAP kinase inhibitory activity, with an IC 50 value of 0.435 μM. J-1149 can be used for liver fibrosis research.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Signaling Pathways > TGF-β Receptor | Products > Signaling Pathways > p38 MAPK
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。